- Home
- KURA vs BMM Comparison
KURA vs BMM Comparison
Compare KURA & BMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | BMM |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 27 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 765.8M | 654.0M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | BMM |
|---|---|---|
| Price | $8.91 | $7.32 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.56 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 119.4K |
| Earning Date | 05-12-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | N/A |
| Revenue Next Year | $106.37 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.45 | $3.47 |
| 52 Week High | $12.49 | $8.63 |
Technical Indicators
Market Signals| Indicator | KURA | BMM |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 52.38 |
| Support Level | $8.09 | $4.79 |
| Resistance Level | $10.34 | $8.53 |
| Average True Range (ATR) | 0.37 | 0.52 |
| MACD | -0.06 | -0.15 |
| Stochastic Oscillator | 26.25 | 22.70 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About BMM Blue Moon Metals Inc. Common Shares
Blue Moon Metals Inc is a Canadian exploration stage company which is focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The company also holds the Yava polymetallic project in Nunavut that is in the same volcanic lithologies and south of Glencore's Hackett River deposit. The company is focusing on advancing the Blue Moon and Yava properties.